Advertisement

PharmacoEconomics & Outcomes News

, Volume 836, Issue 1, pp 23–23 | Cite as

Recombinant zoster vaccine preferred for older age group

Clinical study
  • 4 Downloads

Reference

  1. Drolet M, et al. Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study. CMAJ: Canadian Medical Association Journal 191: E932-E939, No. 34, 26 Aug 2019. Available from: URL: http://doi.org/10.1503/cmaj.190274

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations